Case Study: GMP Failure Due to Improper Stability Sample Handling
In 2022, a leading pharmaceutical manufacturer received a critical observation from the USFDA during a routine inspection. The issue? Improper handling and documentation of stability samples led to data integrity concerns and a breakdown in traceability. This case study unpacks the root causes, GMP failures, and key takeaways from the incident—helping other organizations prevent similar…
Read More “Case Study: GMP Failure Due to Improper Stability Sample Handling” »